Doseloop Beta

Sodium Picosulfate

medication Under review

A stimulant laxative used to treat constipation or to prepare the bowel for medical procedures.

Research summary

AI-Generated Content: This summary was created by AI and may contain errors. Always verify with peer-reviewed sources.

Human studies in adults show that sodium picosulfate improves stool frequency, straining, and constipation-related symptoms, with benefits demonstrated in randomized placebo-controlled and comparative trials in chronic constipation. It has also been studied for bowel preparation, where it is effective and generally well tolerated. The evidence base is focused on gastrointestinal use rather than broad health optimization. Overall, the research consensus is that sodium picosulfate is an effective stimulant laxative for constipation and bowel cleansing, but it is not a general-purpose supplement. Its main limitations are expected laxative adverse effects such as diarrhea and abdominal discomfort, and its use should be directed toward short-term bowel management rather than routine long-term supplementation.

Reported Benefits

Reported Side Effects

Related health conditions

Research showing how this habit affects specific health conditions. Always consult healthcare professionals.

May Help With

Research (4 studies)

RCT

Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of sodium picosulfate in patients with chronic constipation.

Alimentary Pharmacology & Therapeutics • 2010 • n=367

Mueller-Lissner et al.

RCT

Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial.

Aliment Pharmacol Ther • 2007 • n=274

Guglielmetti S, et al.

RCT

Comparison of bisacodyl and sodium picosulphate in the treatment of chronic constipation.

Current Medical Research and Opinion • 2007 • n=144

Kamm et al.

Preliminary

Sodium picosulfate in opioid-induced constipation: results of an open-label, prospective, dose-ranging study.

International Journal of Clinical Practice • 2006 • n=23

Rogers et al.

Community updates

No updates yet for this supplement.

Be the first to share your experience!

At a glance

Users tracking 0
Linked studies 4
Researched benefits 3
Side effects noted 3